It restrains the effector functions of tumor reactive CD8+ T cells as transduction of with Socs1-targeting microRNA miR-155 into these cells enhances their cytokine responsiveness resulting in improved efficiency to control tumors (37, 38). Here, CD8A is linked to neoplasm.